Does having metabolic syndrome increase my risk of restenosis after Percutaneous Coronary Intervention?

Metabolic syndrome is a cluster of conditions — high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels — that raise your risk for heart disease. After a percutaneous coronary intervention (PCI, also called angioplasty with stenting), there is a chance that the treated artery may narrow again, a process called restenosis. You might wonder if having metabolic syndrome makes restenosis more likely. Based on the available research, the answer is not straightforward: one study found no increased risk, while other research suggests that related factors, such as insulin resistance, could contribute.

What the research says

A 2005 study from the GENDER project followed 901 patients after successful PCI, of whom about half had metabolic syndrome. After adjusting for other risk factors, the researchers found no significant increase in the need for repeat procedures (target vessel revascularization) or in combined outcomes like death, heart attack, or repeat revascularization among those with metabolic syndrome ⁹. This suggests that metabolic syndrome itself may not be a strong independent risk factor for restenosis.

However, a 2024 meta-analysis looked at a marker of insulin resistance called the triglyceride-glucose (TyG) index. Insulin resistance is a key feature of metabolic syndrome. The analysis, which included over 3,900 patients, found that each unit increase in the TyG index was linked to a 42% higher risk of in-stent restenosis ¹⁰. This indicates that the metabolic abnormalities underlying metabolic syndrome, particularly insulin resistance, may indeed play a role in restenosis.

Other factors that can affect outcomes after PCI include the type of stent used, the use of imaging during the procedure, and participation in cardiac rehabilitation. For example, a meta-analysis found that using intravascular imaging (like IVUS or OCT) during PCI reduced major adverse cardiac events in older adults ⁸. Cardiac rehabilitation after PCI has also been shown to lower the risk of major adverse cardiac events and death ⁶. These strategies may be especially important for patients with metabolic syndrome, even though the direct link to restenosis is not fully established.

What to ask your doctor

• Given my metabolic syndrome, what is my personal risk of restenosis after PCI?
• Should I have my insulin resistance or triglyceride-glucose index checked to better understand my risk?
• Would using advanced imaging (like IVUS or OCT) during my stent procedure be beneficial for me?
• Is cardiac rehabilitation recommended for me after PCI, and how can it help reduce my risks?
• Are there specific lifestyle changes or medications that could lower my chance of restenosis?